Physiomics (PYC) Stock Chart & Stock Price History GBX 0.69 +0.02 (+2.52%) (As of 03:27 AM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Physiomics Stock Price Performance 5 Day Performance-3.85%1 Month Performance0.00%3 Month Performance-8.16%6 Month Performance-50.73%Year-To-Date Performance-57.81%1 Year Performance-60.29% Receive PYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Physiomics and its competitors with MarketBeat's FREE daily newsletter. Email Address Central Bank Abandons USD (Ad)You know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our exploding national debt, VOTE FOR GOLD! Get Your FREE Gold Investor Kit NOW! PYC Stock Chart for Friday, November, 22, 2024 PYC Chart by TradingView Physiomics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/21/2024GBX 0.67GBX 0.68+1.05%GBX 0.70GBX 0.68174,292 shs£1.37 million11/20/2024GBX 0.71GBX 0.67-5.25%GBX 0.71GBX 0.67799,674 shs£1.36 million11/19/2024GBX 0.69GBX 0.71+2.62%GBX 0.72GBX 0.691.24 million shs£1.43 million11/18/2024GBX 0.70GBX 0.69-2.14%GBX 0.69GBX 0.671.28 million shs£1.40 million11/15/2024GBX 0.65GBX 0.70+8.00%GBX 0.70GBX 0.68865,195 shs£1.43 million11/14/2024GBX 0.65GBX 0.65-0.31%GBX 0.70GBX 0.65150,000 shs£1.32 million Get the Latest News and Ratings for PYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Physiomics and its competitors with MarketBeat's FREE daily newsletter. 11/13/2024GBX 0.70GBX 0.65-6.86%GBX 0.68GBX 0.65305,904 shs£1.33 million11/12/2024GBX 0.66GBX 0.70+5.74%GBX 0.70GBX 0.65145,846 shs£1.42 million11/11/2024GBX 0.70GBX 0.66-5.43%GBX 0.75GBX 0.66680,692 shs£1.35 million11/08/2024GBX 0.70GBX 0.67-4.43%GBX 70GBX 0.657.66 million shs£1.36 million11/07/2024GBX 0.65GBX 0.70+7.69%GBX 0.70GBX 0.631.11 million shs£1.42 million11/06/2024GBX 0.62GBX 0.65+5.35%GBX 0.65GBX 0.62108,858 shs£1.32 million11/05/2024GBX 0.64GBX 0.62-3.89%GBX 0.66GBX 0.61228,041 shs£1.25 million11/04/2024GBX 0.65GBX 0.64-1.23%GBX 0.70GBX 0.64972,164 shs£1.31 million11/01/2024GBX 0.65GBX 0.64-1.54%GBX 0.67GBX 0.643.92 million shs£1.30 million10/31/2024GBX 0.64GBX 0.65+2.20%GBX 0.65GBX 0.632.56 million shs£1.32 million10/30/2024GBX 0.64GBX 0.64GBX 0.65GBX 0.632.37 million shs£1.29 million10/29/2024GBX 0.65GBX 0.64-1.85%GBX 0.69GBX 0.613.45 million shs£1.29 million10/28/2024GBX 0.65GBX 0.65-0.31%GBX 0.65GBX 0.60248,873 shs£1.32 million10/25/2024GBX 0.66GBX 0.65-1.37%GBX 0.66GBX 0.631.58 million shs£1.32 million10/24/2024GBX 0.67GBX 0.66-0.90%GBX 0.66GBX 0.61806,507 shs£1.34 million10/23/2024GBX 0.68GBX 0.67-1.48%GBX 0.68GBX 0.632.54 million shs£1.35 million10/22/2024GBX 0.66GBX 0.68+2.58%GBX 0.68GBX 0.653.02 million shs£1.37 million10/21/2024GBX 0.68GBX 0.66-2.52%GBX 0.67GBX 0.653.38 million shs£1.34 million Related Companies Roquefort Therapeutics Stock Chart Fusion Antibodies Stock Chart Oxford BioDynamics Stock Chart BSF Enterprise Stock Chart Destiny Pharma Stock Chart Theracryf Stock Chart ValiRx Stock Chart Ovoca Bio Stock Chart Oxford Cannabinoid Technologies Stock Chart Nuformix Stock Chart Receive PYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Physiomics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:PYC) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredAmerica’s Pro-Crypto AgendaCash In On the Pro-Crypto America 27 experts reveal their top picks for 2025 Crypto 101 Media | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Physiomics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Physiomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
